Home › Non-Small Cell Lung Cancer › Hawaii › Honolulu

Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Honolulu, HI

Isang pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Honolulu. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Nagre-recruitPhase 3

Kaiser Permanente Moanalua Medical Center /ID# 238363, Honolulu

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT04928846

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Nagre-recruitPhase 2

Kaiser Permanente Moanalua Medical Center /ID# 272916, Honolulu

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06568939

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Nagre-recruitPhase 3

Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
Queen's Cancer Cenrer - POB I, Honolulu
Queen's Medical Center, Honolulu
at 5 pa

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT04267848

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Nagre-recruitPhase 3

Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
Queen's Cancer Cenrer - POB I, Honolulu
Queen's Medical Center, Honolulu
at 4 pa

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06498635

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

Nagre-recruitPhase 3

The Queens Medical Center, Honolulu

Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06899126

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Nagre-recruitPhase 2

Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
Queen's Cancer Cenrer - POB I, Honolulu
Queen's Medical Center, Honolulu
at 2 pa

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Nagre-recruitPhase 2

Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
Queen's Cancer Cenrer - POB I, Honolulu
Queen's Medical Center, Honolulu
at 6 pa

Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT06116682

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Nagre-recruit

Spark M. Matsunaga VA Medical Center, Honolulu

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 30, 2026 · NCT05297734

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Nagre-recruitObservasyonal na pag-aaral

Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
Queen's Cancer Center - POB I, Honolulu
Queen's Medical Center, Honolulu
at 9 pa

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06418204

GEMINI-NSCLC: NSCLC Biomarker Study

Nagre-recruitObservasyonal na pag-aaral

Hawaii Cancer Care, Honolulu

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 5, 2026 · NCT05236114

Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod

Iba pang pag-aaral sa Honolulu

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.